- Published on
Medicine - Immunoglobulin M (IgM)
Immunoglobulin M (IgM) is the first antibody class typically produced during a primary immune response.
It is particularly effective at agglutination, activation of the classical complement pathway and early defence against bloodstream infections.
- Secreted IgM is predominantly a pentamer.
- IgM pentamers usually contain a J chain.
- IgM is produced early in the primary immune response.
- IgM is an excellent agglutinating antibody.
- IgM strongly activates classical complement.
- Many ABO blood group antibodies are IgM.
1. Structure of IgM
A. Pentameric Structure
Secreted IgM is predominantly a pentamer, consisting of five immunoglobulin monomers joined by disulfide bonds and usually a J chain.
Each monomer contains:
- Two mu (μ) heavy chains.
- Two light chains (kappa or lambda).
- Two antigen-binding sites.
Pentameric IgM has 10 potential antigen-binding sites, giving it high overall avidity.
B. Membrane-Bound IgM
- Membrane-bound IgM is monomeric.
- Expressed on developing and mature B lymphocytes.
- Functions as part of the B-cell receptor.
2. IgM in the Primary Immune Response
IgM is typically the first antibody class produced after initial exposure to a new antigen.
- An antigen enters the body.
- Naive B cells recognise the antigen.
- B cells become activated.
- Early IgM production occurs.
- Some B cells undergo class-switch recombination.
- IgG, IgA or IgE may subsequently be produced.
Primary Versus Secondary Response
Primary response:
- IgM is typically produced first.
- Antibody response is initially slower.
- Affinity maturation and class switching may follow.
Secondary response:
- Memory B cells respond more rapidly.
- Class-switched antibodies are often prominent.
- IgM may still be produced.
3. IgM and Agglutination
Agglutination is the clumping of particles such as bacteria or red blood cells following antibody binding.
Pentameric IgM has multiple antigen-binding sites, allowing it to bind several particles simultaneously.
Effects:- Clumping of microorganisms.
- Reduced microbial dissemination.
- Enhanced immune clearance.
4. IgM and Complement Activation
IgM is a highly efficient activator of the classical complement pathway when bound to antigen.
Mechanism
- IgM binds an antigen on a bacterial surface.
- Antigen-bound IgM recruits C1q.
- The classical complement pathway is activated.
- C3b is deposited on the bacterial surface.
- Complement receptors recognise deposited C3b.
- Phagocytosis is enhanced.
Visual Flowchart
5. IgM and Blood Group Antibodies
Many naturally occurring ABO blood group antibodies are predominantly IgM.
- Blood group A: Anti-B antibodies.
- Blood group B: Anti-A antibodies.
- Blood group AB: Usually neither anti-A nor anti-B.
- Blood group O: Anti-A and anti-B antibodies.
These antibodies develop after birth, likely in response to environmental antigens resembling ABO carbohydrates.
ABO-Incompatible Transfusion
- Incompatible red blood cells enter circulation.
- Pre-existing ABO antibodies bind red cell antigens.
- Classical complement is activated.
- Intravascular haemolysis may occur.
- Severe reactions may cause shock, acute kidney injury or DIC.
6. IgM and Neonatal Immunity
- IgM does not significantly cross the placenta.
- IgM is low but detectable at birth.
- The fetus can produce IgM before birth.
- Elevated pathogen-specific neonatal IgM may support congenital infection.
- Congenital rubella.
- Congenital toxoplasmosis.
- Congenital cytomegalovirus.
7. Important Properties of IgM
- Secreted IgM is predominantly pentameric.
- Usually contains a J chain.
- Membrane-bound IgM is monomeric.
- Contains mu heavy chains.
- First antibody class in the primary response.
- Highly effective at agglutination.
- Strong classical complement activator.
- Promotes C3b-mediated opsonisation.
- Predominantly intravascular.
- Does not significantly cross the placenta.
- Includes many naturally occurring ABO antibodies.
8. Clinical Associations
A. Acute ABO-Incompatible Transfusion Reaction
- Pre-existing ABO antibodies, commonly IgM.
- Complement activation.
- Intravascular haemolysis.
- Potentially life-threatening.
B. Cold Agglutinin Disease
- Usually involves IgM autoantibodies.
- Red blood cell binding at lower temperatures.
- Complement activation and haemolysis.
- May cause anaemia, jaundice and acrocyanosis.
C. Waldenstrom Macroglobulinaemia
- Lymphoplasmacytic lymphoma producing monoclonal IgM.
- May cause hyperviscosity syndrome.
- Can cause anaemia and peripheral neuropathy.
- May cause lymphadenopathy or splenomegaly.
D. Selective IgM Deficiency
- Rare antibody deficiency.
- May cause recurrent infections.
- Can be associated with autoimmune or allergic disorders.
9. Important Corrections
- Secreted IgM is pentameric; membrane IgM is monomeric.
- IgM pentamers usually contain a J chain.
- IgM is typically the first antibody produced in a primary response.
- IgM has high avidity and excellent agglutinating ability.
- IgM strongly activates classical complement.
- Opsonisation is mainly indirect through C3b deposition.
- ABO antibodies are commonly IgM, but some are IgG.
- IgM does not significantly cross the placenta.
- IgM positivity does not always prove acute infection.
10. High-Yield Examination Summary
- Secreted IgM: Pentamer with J chain.
- Membrane IgM: Monomer.
- Mu heavy chains.
- Primary immune response.
- Strong agglutination.
- Classical complement activation.
- Indirect opsonisation through C3b.
- ABO blood group antibodies.
- Acute haemolytic transfusion reactions.
- Cold agglutinin disease.
- Waldenstrom macroglobulinaemia.
- Does not cross the placenta.
- Pathogen-specific neonatal IgM may suggest congenital infection.
Medicine - Immunology Revision Notes